Company intelligence / Profile preview

Sulzer

Winterthur, Zurich canton, Switzerlandsulzer.com ↗

Ownership: Public · SUN
Employees: ~13000
Development stage: Other

Overview

Sulzer is a global leader in fluid engineering, process technology, and industrial manufacturing. Through its Applicator Systems division—including the acquired companies Haselmeier and Medmix—Sulzer provides advanced drug delivery devices such as subcutaneous self-injection pens for chronic conditions like diabetes and osteoporosis. The company does not develop drugs or biologics but enables pharmaceutical administration through innovative device platforms[6][10].

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Emirates Biotech (technology licensing for biopolymer production)

Financials

Market cap: $10.6B
Total revenue: $14.3B
Enterprise value: $24.7B

Beyond the preview

Go deeper on Sulzer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulzer.

Explore the full profile